Hari K.
Akula
ab,
Hariprasad
Kokatla
a,
Graciela
Andrei
c,
Robert
Snoeck
c,
Dominique
Schols
c,
Jan
Balzarini
c,
Lijia
Yang
a and
Mahesh K.
Lakshman
*ab
aDepartment of Chemistry and Biochemistry, The City College of New York, 160 Convent Avenue, New York, New York 10031, USA. E-mail: mlakshman@ccny.cuny.edu
bThe Ph.D. Program in Chemistry, The Graduate Center of the City University of New York, New York, New York 10016, USA
cLaboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Herestraat 49, Postbus 1043, 3000 Leuven, Belgium
First published on 19th January 2017
Correction for ‘Facile functionalization at the C4 position of pyrimidine nucleosides via amide group activation with (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) and biological evaluations of the products’ by Hari K. Akula, et al., Org. Biomol. Chem., 2017, DOI: 10.1039/c6ob02334g.
b EC50 = 50% effective concentration or compound concentration required to inhibit virus replication by 50%.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2017 |